n,n-dimethylarginine has been researched along with Graft-Versus-Host Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beelen, D; Dai, H; Dreger, P; Kordelas, L; Kumar, R; Luft, T; Müller-Tidow, C; Rachakonda, SP; Radujkovic, A | 1 |
1 trial(s) available for n,n-dimethylarginine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation.
Topics: Allografts; Arginine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Risk Factors; Survival Rate | 2019 |